Back to Newsroom

Novavax to Present at the Stifel 2015 Healthcare Conference

Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Barclay “Buck” Phillips, SVP, Chief Financial Officer and Treasurer, will present at the Stifel 2015 Healthcare Conference.


Read more here.